{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T17:22:07Z","timestamp":1762363327054,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012654","name":"Olga Mayenfisch Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012654","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004320","name":"Philips","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.nuclcard.2025.102225","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T07:08:43Z","timestamp":1747638523000},"page":"102225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Quantitative radionuclide imaging \u2013 An opportunity to optimize and personalize care of ATTR cardiomyopathy"],"prefix":"10.1016","volume":"47","author":[{"given":"Dominik C.","family":"Benz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah A.M.","family":"Cuddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nuclcard.2025.102225_bib1","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","article-title":"Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy","volume":"46","author":"Perugini","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102225_bib2","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2024.5221","article-title":"Clinical phenotype and prognosis of asymptomatic patients with transthyretin cardiac amyloid infiltration","author":"Porcari","year":"2025","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102225_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2024.102019","article-title":"Quantitative 99mTc-pyrophophate myocardial uptake: changes on transthyretin stabilization therapy","volume":"39","author":"Vijayakumar","year":"2024","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102225_bib4","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jcmg.2011.03.016","article-title":"Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis","volume":"4","author":"Rapezzi","year":"2011","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.nuclcard.2025.102225_bib5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCIMAGING.112.000132","article-title":"(99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses","volume":"6","author":"Bokhari","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.nuclcard.2025.102225_bib6","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/jamacardio.2016.2839","article-title":"Multicenter study of planar technetium 99m pyrophosphate cardiac imaging: predicting survival for patients with ATTR cardiac amyloidosis","volume":"1","author":"Castano","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"2","key":"10.1016\/j.nuclcard.2025.102225_bib7","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s12350-020-02274-2","article-title":"Quantitation of myocardial (99m)Tc-HMDP uptake with new SPECT\/CT cadmium zinc telluride (CZT) camera in patients with transthyretin-related cardiac amyloidosis: ready for clinical use?","volume":"29","author":"Bellevre","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102225_bib8","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.jcmg.2020.03.020","article-title":"DPD quantification in cardiac amyloidosis: a novel imaging biomarker","volume":"13","author":"Scully","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.nuclcard.2025.102225_bib9","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s11604-021-01221-6","article-title":"Usefulness of quantitative (99m)Tc-pyrophosphate SPECT\/CT for predicting the prognosis of patients with wild-type transthyretin cardiac amyloidosis","volume":"40","author":"Ogasawara","year":"2022","journal-title":"Jpn J Radiol"},{"key":"10.1016\/j.nuclcard.2025.102225_bib10","doi-asserted-by":"crossref","DOI":"10.1007\/s00259-025-07092-7","article-title":"Effects of tafamidis on serial [99mTc]Tc-DPD scintigraphy in transthyretin amyloid cardiomyopathy","author":"Ungericht","year":"2025","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.nuclcard.2025.102225_bib11","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.2967\/jnumed.124.267542","article-title":"Deep learning-enabled quantification of (99m)Tc-pyrophosphate SPECT\/CT for cardiac amyloidosis","volume":"65","author":"Miller","year":"2024","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nuclcard.2025.102225_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.101261","article-title":"DPD quantification correlates with extracellular volume and disease severity in wild-type transthyretin cardiac amyloidosis","volume":"3","author":"Rettl","year":"2024","journal-title":"JACC Adv"},{"key":"10.1016\/j.nuclcard.2025.102225_bib13","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1007\/s12350-023-03203-9","article-title":"Diagnostic performance characteristics of planar quantitative and semi-quantitative parameters of Tc99m pyrophosphate (PYP) imaging for diagnosis of transthyretin (ATTR) cardiac amyloidosis: the SCAN-MP study","volume":"30","author":"Pandey","year":"2023","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102225_bib14","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1007\/s12350-019-01760-6","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging","volume":"26","author":"Dorbala","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102225_bib15","doi-asserted-by":"crossref","first-page":"102199","DOI":"10.1016\/j.nuclcard.2025.102199","article-title":"Validation of [99mTc]Tc-HMDP SPECT\/CT myocardium-to-blood ratio for the detection of ATTR cardiomyopathy","author":"Suomalainen","year":"2025","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102225_bib16","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1007\/s12350-022-03059-5","article-title":"Radiopharmaceutical supply disruptions and the use of 99mTc-hydroxymethylene disphophonate as an alternative to 99mTc-pyrophosphate for the diagnosis of transthyretin cardiac amyloidosis: an ASNC Information Statement","volume":"29","author":"Miller","year":"2022","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2025.102225_bib17","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1007\/s00259-020-04753-7","article-title":"Extracardiac soft tissue uptake, evidenced on early 99mTc-HMDP SPECT\/CT, helps typing cardiac amyloidosis and demonstrates high prognostic value","volume":"47","author":"Malka","year":"2020","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"10.1016\/j.nuclcard.2025.102225_bib18","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1053\/j.semnuclmed.2024.05.012","article-title":"Radionuclide imaging of cardiac amyloidosis: an update and future aspects","volume":"54","author":"Clerc","year":"2024","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.nuclcard.2025.102225_bib19","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/ehjci\/jeae295","article-title":"Prognostic implication of DPD quantification in transthyretin cardiac amyloidosis","volume":"26","author":"Rettl","year":"2025","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.nuclcard.2025.102225_bib20","doi-asserted-by":"crossref","first-page":"944","DOI":"10.2967\/jnumed.123.266926","article-title":"Prognostic value of [99mTc]Tc-DPD quantitative SPECT\/CT in patients with suspected and confirmed amyloid transthyretin-related cardiomyopathy and preserved left ventricular function","volume":"65","author":"Caobelli","year":"2024","journal-title":"J Nucl Med"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358125000996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358125000996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T17:17:28Z","timestamp":1762363048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358125000996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":20,"alternative-id":["S1071358125000996"],"URL":"https:\/\/doi.org\/10.1016\/j.nuclcard.2025.102225","relation":{},"ISSN":["1071-3581"],"issn-type":[{"type":"print","value":"1071-3581"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative radionuclide imaging \u2013 An opportunity to optimize and personalize care of ATTR cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nuclcard.2025.102225","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.nuclcard.2024.102199","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of American Society of Nuclear Cardiology.","name":"copyright","label":"Copyright"}],"article-number":"102225"}}